Discovery of novel TAK-285 derivatives as EGFR/HER2 inhibitors withantiproliferative properties against PC3 and 22RV1 prostate cancer cell lines
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.